Wuhan Keqian Biology Co.,Ltd reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 388.08 million compared to CNY 538.21 million a year ago. Revenue was CNY 393.63 million compared to CNY 545.05 million a year ago.

Net income was CNY 159.11 million compared to CNY 286.14 million a year ago. Basic earnings per share from continuing operations was CNY 0.34 compared to CNY 0.62 a year ago. Diluted earnings per share from continuing operations was CNY 0.34 compared to CNY 0.62 a year ago.